Acute Pancreatitis Market Research by Types of Testing (Transabdominal Ultrasound, Endoscopic Ultrasound (EUS), Magnetic Resonance Cholangiopancreatography (MRCP), Computerized Tomography (CT)), by Types of Treatment (Fluids, Nutritional Support, Treatment of Underlying Issues, Endoscopic Retrograde Cholangiopancreatography (ERCP)) – Forecast To 2022
Market Overview
Acute pancreatitis (AP) is a systemic immunoinflammatory response to auto-digestion of the pancreas and peri-pancreatic organs.
Antibiotics are usually not recommended in patients with acute pancreatitis, regardless of the type or disease severity. Infection must be suspected in patients who have signs of deterioration such as fever, increasing WBC count.
The global acute pancreatitis market is expected to grow at a CAGR of 3.5% during forecasted period 2017-2023.
Get Free Sample at: https://www.marketresearchfuture.com/sample_request/1565
Most infections in pancreatic necrosis are caused by single bacterial species from the gut. In patients with infected necrosis, antibiotics known to penetrate pancreatic necrosis, such as carbapenems, fluoroquinolones, and metronidazole, are recommended. Byetta (exanitide) is a drug from Eli Lily and Company that is FDA approved to treat acute pancreatitis.
Some of the key players in this market are: Abbott Laboratories (US), McNeil Consumer Healthcare (US), Sun BioPharma, Inc (US), university’s and institutes are also included in the treatment of acute pancreatic like Radboud University, University Medicine Greifswald and others
This condition is common and life threatening disease. With an annual incidence of 4.9–73 cases per 100000 people worldwide. The males are predominantly affected at young ages with a ratio of 2.5:1. The mortality rate for pancreatitis is between 1.5% and 4.2% according to large epidemiological studies, but is a frequent gastrointestinal disease with a morbidity rate of 30% in severe cases.
Segmentation:
On the basis of types of testing which comprises of Transabdominal ultrasound, Endoscopic ultrasound (EUS), Magnetic resonance cholangiopancreatography (MRCP), Computerized tomography (CT) and others
On the basis of type of treatment which consists of Fluids, Nutritional Support, Treatment of Underlying Issues, Endoscopic Retrograde Cholangiopancreatography (ERCP) and others.
On the basis of type of therapy which consists of Massage Therapy, Therapeutic Touch, Acupuncture and others
Brows Complete Detailed Research Report at: https://www.marketresearchfuture.com/reports/acute-pancreatitis-market-1565
Regardless of the technological advances in critical care drugs in the course of recent years, the death rate has prevailed to approximately 10%. Acute pancreatitis is confirmed by medical history, physical examination, and typically a blood test (amylase or lipase) for digestive enzymes of the pancreas. The diagnosis of pancreatic is often difficult and treatments are therefore delayed because the organ is relatively inaccessible.
Regional Analysis:
Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.
The North America dominated the global acute pancreatitis market with the U.S. holding the largest market share owing to numerous developments in the medical sector, and rising numbers of research institutes for better treatment of this diseases. The reported annual incidence of acute pancreatitis has ranged from 4.9 to 35 per 100,000 population. Acute pancreatitis is the leading gastrointestinal cause of hospitalization in the United States.
In Europe, the market for multiple sclerosis is expected to exhibit positive growth during the forecast period. The incidence of acute pancreatitis varies across Europe with gallstone dominantly spread across southern Europe and alcohol in Eastern Europe. The incidence of acute pancreatitis is increasing in many European and Scandinavian countries due to increased alcohol consumption and better diagnostic capability.
Whereas Asia Pacific is expected to be a growing market for Acute Pancreatitis market and expected to grow at a rapid rate. The Middle East & African market especially, the African region is expected to witness a poor growth owing to the lack of knowledge in medical sector, and less development in medical facilities in Middle East & Africa will have limited growth in the market.
Inquire for any Query at https://www.marketresearchfuture.com/enquiry/1565
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/acute-pancreatitis-market-1565